PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Nat Neurosci. Author manuscript; available in PMC Feb 1, 2011.
Published in final edited form as:
PMCID: PMC2910780
NIHMSID: NIHMS211272
Competitive regulation of synaptic Ca influx by D2 dopamine and A2A adenosine receptors
Michael J. Higley* and Bernardo L. Sabatini
Howard Hughes Medical Institute, Department of Neurobiology, Harvard Medical School, Boston, MA 02115
Correspondence: bsabatini/at/hms.harvard.edu
*Current address: Department of Neurobiology, Program in Cellular Neuroscience, Neurodegeneration, and Repair, Yale School of Medicine, New Haven, CT 06510
MJH conducted the experiments and data analysis. MJH and BLS designed the experiments and wrote the manuscript.
Striatal D2-type dopamine receptors (D2Rs) are implicated in the pathophysiology of neuropsychiatric disorders, including Parkinson’s disease and schizophrenia. Although these receptors regulate striatal synaptic plasticity, the mechanisms underlying dopaminergic modulation of glutamatergic synapses are unclear. We combined optogenetics, 2-photon microscopy, and glutamate uncaging to examine D2R-dependent modulation of glutamatergic synaptic transmission in mouse striatopallidal neurons. We find that D2R activation reduces corticostriatal glutamate release and attenuates both synaptic- and action potential-evoked Ca influx into dendritic spines by approximately 50%. Modulation of Ca signaling is mediated by a PKA-dependent regulation of Ca entry through NMDA-type glutamate receptors that is inhibited by D2Rs and enhanced by activation of 2A-type adenosine receptors (A2ARs). D2Rs also produce a PKA- and A2AR-independent reduction in Ca influx through R-type voltage-gated Ca channels. These findings reveal that dopamine regulates spine Ca by multiple pathways and that competitive modulation of PKA controls NMDAR-mediated Ca signaling in the striatum.
The striatum is the first processing stage in the basal ganglia, a collection of forebrain nuclei whose function is critical for the generation of coordinated, purposeful movements 1. Regulation of striatal activity by dopamine (DA) is important for a variety of psychomotor functions including habit learning and serial movement, and perturbation of dopaminergic signaling is central to the pathogenesis of several neuropsychiatric diseases 24. DA release within the striatum activates two classes of G-protein coupled receptors expressed by distinct subpopulations of medium spiny neurons (MSNs), the principal striatal cells. Type 2 dopamine receptors (D2Rs), expressed by striatopallidal MSNs, are linked to behavioral disorders including Parkinson’s disease, obsessive-compulsive disorder, and schizophrenia 2,4,5. D2Rs are coupled to Gαi, 2,3,6, whose activation triggers a divergent cascade of signaling pathways, reducing cAMP production and protein kinase A (PKA) activity while simultaneously enhancing phospholipase C-dependent (PLC) processes and the release of calcium (Ca) from internal stores 3,4,6. Striatopallidal MSNs also express the Gαs-coupled type 2A adenosine receptor (A2AR) whose activation elevates cAMP and PKA activity and may counteract the actions of D2Rs 7. Nevertheless, the cellular targets of dopaminergic and adenosinergic signaling are not well characterized.
The expression of D2Rs on dendritic shafts and spines, as well as on afferent glutamatergic terminals, suggests that a key feature of D2R-mediated modulation may be the control of excitatory synaptic transmission 8. Activation of D2Rs has been reported to inhibit postsynaptic glutamate receptors stimulated by exogenous agonists 9 and also to reduce glutamate release, although it remains unclear whether this effect is mediated by pre- or postsynaptic D2Rs 10,11. D2R activation also reduces whole-cell Ca influx through voltage-gated Ca channels (VGCCs) 1214, although the consequences for synaptic Ca influx are unknown. Indeed, recent work suggests that D2Rs might indirectly boost synaptic Ca influx by decreasing acetylcholine release from local interneurons, relieving cholinergic inhibition of dendritic VGCCs 15. Functionally, D2R activation promotes long-term depression (LTD) of striatal excitatory synapses while reducing NMDA-type glutamate receptor (NMDAR)-dependent long-term potentiation (LTP) 1619. The former is thought to rely on a D2R-mediated, PLC-dependent enhancement of endocannabinoid release 20,21, while mechanisms underlying the latter are unknown.
To gain insight into D2R actions on synaptic transmission, we combined electrophysiological recordings and 2-photon imaging of striatopallidal MSNs with optical activation of glutamatergic synapses using Channelrhodopsin-2 and focal glutamate uncaging. Our results reveal that D2Rs reduce corticostriatal glutamatergic transmission without directly altering current through postsynaptic glutamate receptors. Instead, D2R activation selectively inhibits Ca influx through both NMDARs and R-type VGCCs. Regulation of NMDARs is mediated by a PKA-dependent pathway and can be prevented by co-activation of A2ARs. In contrast, modulation of R-type Ca influx is independent of PKA and A2AR activity. Our findings indicate that D2Rs engage a divergent signaling cascade controlling synaptic Ca influx and demonstrate a competition between A2ARs and D2Rs for the regulation of Ca influx through NMDARs.
To investigate D2R actions on glutamatergic responses in striatopallidal MSNs, we made whole-cell current clamp recordings from GFP-positive cells in acute slices prepared from mice expressing GFP under control of the D2R gene promoter (Fig. 1a) 15,22. Membrane potential was held near −60 mV, and experiments were done in the presence of the muscarinic antagonist scopolamine.
Figure 1
Figure 1
Modulation of corticostriatal synaptic responses in striatopallidal MSNs by D2Rs
To examine modulation of corticostriatal synapses, we expressed Channelrhodopsin-2 (ChR2) in motor cortex neurons projecting to the striatum (Fig. 1b, see methods). Pulses of blue light applied to the striatum surrounding the current-clamped MSN reliably evoked excitatory postsynaptic potentials (EPSPs, Fig. 1c). Bath application of the D2R agonist quinpirole reduced the average EPSP amplitude from 9.6 ± 1.2 mV to 7.0 ± 1.4 mV (n=7, paired Student’s t-test, p<0.01, Fig. 1d). In voltage-clamp recordings, application of quinpirole reduced light-evoked excitatory postsynaptic currents (EPSCs) from 101.4 ± 23.2 pA to 78.6 ± 19.4 pA (n=8, p<0.01, Fig. 1e). Notably, quinpirole failed to alter EPSPs evoked by local electrical stimulation (Supplemental Fig. 1), suggesting that electrical stimulation may trigger local release of dopamine, occluding the actions of exogenous agonists 11.
Previous studies indicated that D2R activation reduces glutamate release from corticostriatal terminals 10,11, potentially explaining the inhibition of light-evoked EPSPs and EPSCs. Evidence for direct D2R modulation of postsynaptic glutamate receptors has been less conclusive. We combined 2-photon laser scanning microscopy and glutamate uncaging to bypass presynaptic terminals and examine modulation of glutamatergic responses at single postsynaptic sites. Cells were filled with the Ca-insensitive red fluorophore Alexa Fluor 594 and the Ca-sensitive green fluorophore Fluo-5F. Under current clamp, a 500 μs pulse from the uncaging laser directed 0.5 μm from a dendritic spine located within 60 μm of the cell body produced a small uncaging-evoked EPSP (uEPSP) and a Ca-dependent increase in green fluorescence in the spine head and neighboring dendritic shaft (Fig. 2a). Fluorescence transients in the spine and dendrite were quantified as the percent increase in green signal relative to the maximal green fluorescence in saturating Ca (ΔGsp/Gsat and ΔGden/Gsat, respectively, see methods). For each synapse, laser power was adjusted such that the uncaging pulse applied directly to the spine head bleached ~50% of the red fluorescence (Fig. 2b) 23 and the periphery of the spine head was probed to find the uncaging position that evoked the largest uEPSP 24.
Figure 2
Figure 2
D2R modulation of uncaging-evoked Ca transients in active spines
Under control conditions, a single uncaging pulse produced an average (n=36) uEPSP and associated Ca transients in the spine and neighboring dendritic shaft with amplitudes of 1.1 ± 0.1 mV, 7.4 ± 0.5%, and 1.9 ± 0.2%, respectively (Fig. 2c,d). Because MSN dendrites exhibit voltage-dependent conductances that can shape temporal integration of synaptic inputs 25,26, we also measured the average uEPSP (2.0 ± 0.2 mV) and Ca transients (ΔGsp/Gsat = 15.8 ± 1.1%, ΔGden/Gsat = 4.7 ± 0.2%) evoked by a burst of uncaging pulses (three stimuli, 20 ms inter-stimulus interval, Fig. 2c,d). In the presence of quinpirole (n=23), there was no significant change in average peak uEPSP magnitude for either single (1.2 ± 0.1 mV, p=0.61) or triple (1.6 ± 0.2 mV, p=0.14) stimuli (Fig. 2c,d) compared to control conditions, although the decay of the triple response was slightly faster, possibly indicating changes in voltage-gated ion channel or NMDAR contributions. In contrast, quinpirole strongly reduced uncaging-evoked Ca influx following both single (ΔGsp/Gsat = 4.2 ± 0.4%, p<0.0001, ΔGden/Gsat = 0.9 ± 0.1%, p<0.0001) and triple (ΔGsp/Gsat = 9.4 ± 0.8%, p<0.0001, ΔGden/Gsat = 1.9 ± 0.2%, p<0.001) stimuli (Fig. 2c,d). Quinpirole did not alter the kinetics of recovery following photobleaching of the red fluorophore (50.7 ± 5.2 ms versus 58.6 ± 10.4 ms for control and quinpirole, respectively, p=0.45, Fig. 2b), indicating a lack of change in the diffusional properties of the spine. Furthermore, temporal summation of uEPSPs and Ca transients were not significantly altered by quinpirole (Supplemental Fig. 2). In summary, when bypassing the presynaptic terminal, activation of D2Rs in striatopallidal MSNs reduces synaptic Ca influx by nearly 50% with minimal effects on somatic potentials.
Multiple Ca sources contribute to synaptic Ca transients
To identify potential targets of dopaminergic regulation underlying the inhibition of Ca influx, we examined the Ca sources that contribute to synaptic signaling in striatopallidal MSNs. Blockade of NMDARs with the selective antagonist CPP significantly increased the average (n=21) amplitude of the single stimulus uEPSP to 146.3 ± 20.7% of the control value (p<0.05, Fig. 3a,c). This counterintuitive result may reflect the role of NMDARs in promoting the opening of SK-type Ca-activated potassium channels that inhibit synaptic potentials in a variety of cell types 23,27. Indeed, application of the SK channel blocker apamin (0.1 μM) also significantly increased uEPSP amplitude (Supplemental Fig. 3). A 50 Hz burst stimulus revealed that temporal summation was decreased by NMDAR blockade due to reduced uEPSP duration (Fig. 3a,c and Supplemental Fig. 2). CPP reduced the uncaging-evoked Ca influx in the spine head to 14.0 ± 1.3% (p<0.0001) and 9.1 ± 1.0% (p<0.0001) of control values for single and triple stimuli, respectively (Fig. 3a,d), consistent with a dominant contribution of NMDARs to synaptically-evoked Ca transients.
Figure 3
Figure 3
Multiple Ca sources contribute to synaptic Ca signaling
We also analyzed the contribution of VGCCs to synaptic signaling. Selective blockade of P/Q- (n=24), N- (n=26), or L- (n=26) type channels (with 0.2 μM ω-agatoxin-IVA, 1 μM ω-conotoxin GVIA, or 3 μM nimodipine, respectively) had no significant effect on synaptic potentials and Ca transients evoked by single or triple stimuli (Figure 3b–d, p>0.05 for all comparisons). These blockers also failed to alter the temporal summation of uncaging-evoked potentials and Ca transients (Supplemental Fig. 2). As shown previously 28, 20 μM nimodipine did reduce Ca influx (Supplemental Fig. 4), revealing either a loss of channel selectivity at this high concentration 29 or the presence of relatively dihydropyridine-resistant CaV1.3 L-type channels30.
Combined blockade of R-, L-, and T-type channels with mibefradil had no effect on the average (n=18) uEPSP evoked by a single stimulus, although the uEPSP following the triple stimulus was reduced relative to control (Fig. 3b,c). However, mibefradil reduced the average relative amplitude of the Ca transients evoked by both single (77.2 ± 9.5%, p<0.05) and triple (72.9 ± 9.1%, p<0.01) stimuli (Fig. 3b,d). In contrast, selective blockade of R-type channels with SNX-482 produced a significant increase in average (n=20) uEPSP magnitude (Fig. 3b,c). These results suggest that, similar to the hippocampus, blocking R-type channels disengages a negative feedback loop involving SK channels, thereby boosting synaptic potentials and NMDAR-mediated Ca influx 23. The lack of uEPSP boosting and the reduction in burst-evoked uEPSPs by mibefradil suggests that the broad actions of this non-selective agent may influence the generation of synaptic potentials. In summary, our results indicate that the largest fraction of spine Ca influx evoked by activation of a single postsynaptic terminal in striatopallidal MSNs arises from NMDAR opening, with additional contributions from R- and either T- or dihydropyridine-resistant L-type VGCCs, and suggest that these sources are potential targets for dopaminergic control of synaptic Ca influx.
D2Rs inhibit NMDAR- and R-type VGCC-mediated Ca influx
To examine the potential modulation of NMDAR-mediated synaptic responses, MSNs were voltage-clamped at −70 mV using a cesium-based internal solution and bathed in ACSF containing nominally zero extracellular Mg, tetrodotoxin, a full cocktail of VGCC antagonists (see methods), and the AMPA-type glutamate receptor (AMPAR) antagonist NBQX. Under these conditions, glutamate uncaging evoked an average (n=30) excitatory postsynaptic current (uEPSC, 13.0 ± 1.4 pA) and associated Ca transient in the spine head (ΔGsp/Gsat = 26.5 ± 3.0%, Fig. 4a). Activation of D2Rs produced no change in the average (n=27) NMDAR-mediated uEPSC (11.1 ± 1.3 pA, p=0.31) but significantly decreased the Ca transient (ΔGsp/Gsat = 17.0 ± 2.1%, p<0.05, Fig. 4a). Similar analysis was performed for non-NMDAR-mediated responses using ACSF with control Mg concentration and in the presence of the NMDAR antagonist CPP. The average (n=19) non-NMDAR-mediated uEPSC (26.0 ± 3.6 pA) and associated Ca transient (ΔGsp/Gsat = 0.7 ± 0.1%) were not altered in the presence of quinpirole (n=16; 30.2 ± 2.9 pA, p=0.39; ΔGsp/Gsat = 0.8 ± 0.1%, p=0.62, Fig. 4b), indicating that D2Rs selectively reduce Ca accumulation resulting from activation of NMDARs.
Figure 4
Figure 4
Activation of D2Rs modulates NMDAR- but not non-NMDAR-mediated synaptic responses
The actions of D2Rs on VGCCs were determined by examining the modulation of Ca transients evoked by back-propagating action potentials (bAPs, Fig. 5a). On average (n=30), a single bAP evoked by brief somatic current injection resulted in Ca influx within the spine head (ΔGsp/Gsat = 8.8 ± 0.01%) and neighboring dendrite (ΔGden/Gsat = 6.7 ± 0.4%, Fig. 5b). During a brief burst of three bAPs, Ca further increased in both compartments (ΔGsp/Gsat = 22.0 ± 1.6%, ΔGden/Gsat = 17.4 ± 1.2%, Fig. 5b, Supplemental Fig. 2). Activation of D2Rs reduced the average (n=34) bAP-evoked Ca transient for both single (ΔGsp/Gsat = 5.4 ± 0.5%, p<0.0001; ΔGden/Gsat = 4.2 ± 0.4%, p<0.0001) and triple (ΔGsp/Gsat = 15.0 ± 1.2%, p<0.001; ΔGden/Gsat = 11.9 ± 0.9%, p<0.001; Fig. 5b–d) stimuli, suggesting that VGCCs are targets of D2R modulation. Quinpirole did not alter the temporal summation (Supplemental Fig. 2) or exponential decay time constants of the bAP-evoked spine Ca transients (75.6 ± 6.3 ms versus 82.6 ± 9.4 ms for control and quinpirole, respectively, p=0.55), suggesting a lack of effect on Ca clearance.
Figure 5
Figure 5
Activation of D2Rs modulates R-type voltage-gated Ca channels
In the presence of mibefradil, the average (n=24) single bAP-evoked Ca signal was reduced to 33.4 ± 2.8% (p<0.0001) and 42.6 ± 3.9% (p<0.0001) of control values for spines and dendrites, respectively, indicating a large contribution of R-, T-, and/or L-type channels (Fig. 5c,d). The selective R-type blocker SNX-482 also reduced single bAP-evoked Ca influx to 70.0 ± 5.6% (n=23, p<0.0001) and 77.8 ± 7.3% (p<0.01) of control values for spines and dendrites, respectively (Fig. 5c,d). In contrast, no change in Ca influx was observed in the presence of ω-agatoxin IVA (n=23), ω-conotoxin-GVIA (n=22), or 3 μM nimodipine (n=20) (Fig. 5c,d). Similar results were seen following bursts of three bAPs (Fig. 5c,d), and none of the VGCC blockers altered the temporal summation of bAP-evoked Ca signals (Supplemental Fig. 2). These results suggest that R-type as well as T- and/or dihydropyridine-resistant L-type channels contribute to bAP-evoked Ca influx.
We next examined the ability of mibefradil and SNX-482 to mimic and occlude the actions of quinpirole (Fig. 5c,d). A one-way ANOVA revealed significant differences between the effects on single bAP-evoked Ca transients of mibefradil, SNX-482, quinpirole alone, and each of the VGCC blockers in the presence of quinpirole (F=13.26, p<0.0001 and F=11.30, p<0.0001 for spines and dendrites, respectively). Tukey’s multiple post-hoc comparisons revealed that SNX-482 mimicked and occluded the actions of quinpirole, while mibefradil produced a significantly larger reduction in Ca influx than either SNX-482 or quinpirole alone (comparisons significant for p<0.05). Similar results were obtained for the triple bAP stimuli, arguing that D2Rs modulate R-type VGCCs with minimal effect on T- or L-type channels.
Previous studies have linked dopaminergic regulation of CaV1.3 L-type channels with MSN spine stability 31. To examine whether these channels were present but either inactive or insensitive to dihydropyridine block 30 during brief synaptic or bAP stimuli, we measured spine Ca influx during 300 ms voltage steps from −70 to 0 mV (Fig. 6a). In the presence of blockers for R-, N-, and P/Q-type VGCCs, we observed a large Ca transient that rapidly reached steady state and decayed following return of the holding potential to baseline. Nimodipine (3 μM) reduced the step-evoked transients from 60.2 ± 2.4% (n=22) to 43.7 ± 2.2% (n=21) (Fig 6b). Activation of D2Rs decreased the amplitude to 36.7 ± 1.4% (n=20) whereas co-application of quinpirole and nimodipine produced an additional reduction to 21.4 ± 2.6% (n=20, Fig. 6b). A one-way ANOVA comparing control, quinpirole, nimodipine, and quinpirole + nimodipine revealed significant differences between these groups (F=54.6, p<0.0001). Post-hoc analysis revealed that quinpirole and nimodipine both significantly reduced Ca influx relative to control, and that the two together produced significantly greater reduction than either alone (comparisons significant for p<0.05). However, calculation of the nimodipine-sensitive component (the arithmetic difference between pre- and post-nimodipine values) indicated that the contribution of L-type VGCCs was unaffected by quinpirole (16.5 ± 2.3% versus 15.3 ± 2.1% ΔG/Gsat, baseline in control and quinpirole, respectively, p>0.05). In summary, our data demonstrate that R-, L-, and T-type VGCCs are present in MSN spines, although R-types are the primary channel regulated by D2Rs.
Figure 6
Figure 6
Voltage-steps reveal L-type Ca channels in MSN spines
D2R modulation via PKA- dependent and independent pathways
Studies in hippocampal neurons indicated that a PKA-dependent mechanism augments Ca influx through NMDARs without altering total current flow 32. We therefore examined whether D2R-mediated inhibition of PKA is responsible for the reduction in NMDAR-mediated Ca influx. We isolated NMDAR-mediated responses as above and tested the ability of PKI(14-22), a membrane permeable specific antagonist of PKA, to mimic and occlude the actions of quinpirole. In the presence of PKI(14-22), the average (n=21) NMDAR-mediated uEPSC was 13.0 ± 1.6 pA and the associated spine Ca transient was 15.8 ± 2.0% and 6.9 ± 1.2% (Fig. 7a,b). Similar results were found using the alternate PKA antagonist H89 (n=19, Fig. 7b). Following co-application of PKI(14-22) and quinpirole (n=20), the uEPSC was 14.9 ± 2.3 pA and the Ca signal was 15.1 ± 1.7% (Fig. 7a, b). A one-way ANOVA comparing control, PKI(14-22), quinpirole, and PKI(14-22) + quinpirole revealed significant differences for Ca transients between these groups (F=6.14, p<0.01). Post-hoc comparisons showed significant differences between control and PKI(14-22) as well as between control and PKI(14-22) + quinpirole, whereas there was no difference between quinpirole alone and in combination with PKI(14-22) (comparisons significant for p<0.05). Thus, antagonism of PKA is sufficient to mimic and occlude the actions of D2Rs on NMDAR-mediated Ca transients.
Figure 7
Figure 7
Push-pull modulation of NMDARs by D2Rs and A2ARs is dependent on PKA activity
Striatopallidal MSNs also express A2ARs, which are positively coupled to PKA via Gαs 7 and oppose the actions of D2Rs on long-term synaptic plasticity in the striatum 19. We examined whether these two modulatory pathways also interact in the control of NMDAR-mediated Ca influx. Application of the specific A2AR agonist CGS-21680 (n=16) resulted in a uEPSC magnitude of 27.8 ± 4.5 pA and a spine Ca transient of 28.5 ± 3.2% (Fig. 7a, b). Co-application of CGS-21680 and quinpirole (n=15) resulted in a uEPSC magnitude of 22.7 ± 3.0 pA and spine Ca transient of 29.5 ± 3.0% (Fig. 7a, b). A one-way ANOVA comparing control, quinpirole, CGS-21680, and CGS-21680 + quinpirole revealed significant differences between these groups (F=3.9, p<0.05). Post-hoc analyses indicated that the uEPSC magnitudes for A2AR and combined A2AR+D2R activation were significantly increased, whereas spine Ca transients did not differ from control values (significant for p<0.05).
We next examined whether basal activation of A2ARs influences Ca influx through NMDARs. Application of the specific A2AR antagonist SCH-58261 (n=19) resulted in a uEPSC magnitude of 8.8 ± 1.8 pA and a spine Ca transient of 8.5 ± 0.7% (Fig. 7b). Co-application of SCH-58261 and quinpirole (n=18) resulted in a uEPSC magnitude of 7.6 ± 1.7 pA and a spine Ca transient of 12.7 ± 2.3% (Fig. 7b). A one-way ANOVA with post-hoc tests comparing control, quinpirole, SCH-58261 and SCH-58261 + quinpirole revealed no significant change in uEPSC magnitude. However, A2AR antagonism alone or in combination with quinpirole significantly reduced synaptic Ca influx, while there was no difference between these two groups. In summary, basal levels of A2AR activation enhance Ca influx through NMDARs and reduction of this activity is sufficient to mimic and occlude the effects of D2R activation. Furthermore, exogenous activation of A2ARs can counteract the D2R-mediated PKA-dependent reduction in synaptic Ca influx, suggesting that modulatory control of PKA exerts a bidirectional influence on NMDAR Ca signaling.
In the hippocampus, NMDARs containing the NR2B-type subunit contribute to particularly large Ca influx 33, and removal of these subunits might explain the reduction in synaptic Ca influx. However, application of the selective NR2B-containing NMDAR antagonist ifenprodil (n=18) revealed no significant change in uEPSC or Ca transient magnitude (Fig. 7b), suggesting that this subgroup of receptors does not contribute substantially to Ca influx under control conditions.
Finally, we examined whether similar PKA-dependent mechanisms underlie the D2R-mediated reduction in bAP-evoked Ca signals. A one-way ANOVA revealed significant differences between spine Ca transients in control, quinpirole, PKI(14-22) (n=20), PKI(14-22) + quinpirole (n=17), and CGS-21680 + quinpirole (n=11) (F=10.3, p<0.0001, Fig. 8a,b). Post-hoc tests indicated that, in the presence of PKI(14-22), Ca influx did not significantly differ from control conditions. Furthermore, co-application of quinpirole and either PKI(14-22) or CGS-21680 produced a reduction in signal that did not differ from that seen with quinpirole alone. Similar results were obtained for dendrite Ca signals (Fig. 8a,b). These findings indicate that the actions of D2Rs on bAP-evoked VGCC-mediated Ca transients occur independently of PKA and A2AR activation and demonstrate that D2Rs couple to two independent pathways that converge on a similar endpoint of reduced Ca signaling in dendritic spines.
Figure 8
Figure 8
Modulation of VGCCs by D2Rs is independent of A2AR and PKA activity
Perturbation of D2R-dependent dopaminergic modulation in the striatum is linked to a variety of neuropsychiatric disorders, including Parkinson’s disease, obsessive-compulsive disorder, and most notably schizophrenia 2,4. Schizophrenic patients show evidence of increased density and occupancy of striatal D2Rs 34, and most effective antipsychotic agents antagonize D2Rs 5,35. Furthermore, overexpression of striatal D2Rs in mice produces behavioral impairments thought to model those seen in neuropsychiatric patients 36. Here, we find that activation of D2Rs reduces glutamate release from cortical afferents and attenuates Ca influx through NMDARs. The regulation of NMDAR Ca signaling occurs via a reduction in PKA activity and can be prevented by co-activation of A2ARs. D2Rs also act via a PKA-independent pathway to reduce Ca signaling through SNX-482-sensitive R-type (CaV2.3) VGCCs. Thus, we demonstrate that D2R activation triggers divergent signaling cascades that inhibit multiple synaptic Ca sources. Furthermore, we provide evidence of a functional synaptic role for D2R-and A2AR-mediated regulation of PKA, implicating this kinase as a target for convergent neuromodulatory control over NMDAR-mediated Ca signaling and a likely substrate for control of synaptic plasticity in the striatum.
Regulation of corticostriatal glutamate release
By using mice in which corticostriatal afferents expressed light-activatable ChR2, we were able to selectively characterize the D2R-mediated modulation of cortical inputs to striatopallidal MSNs. Consistent with previous studies, activation of D2Rs reduced the magnitude of evoked postsynaptic potentials and currents 11. Coupled with the observation that D2Rs failed to alter uncaging-evoked synaptic potentials or currents, our data strongly support the hypothesis that D2Rs regulate corticostriatal transmission by reducing glutamate release from afferent terminals 10,11. However, we cannot conclude whether pre- or postsynaptic D2Rs, possibly coupled to retrograde endocannabinoid signaling, mediate this phenomenon 10,11,37. In contrast, we find no evidence for direct modulation of postsynaptic non-NMDA-type glutamate receptors. Surprisingly, experiments using electrical stimuli revealed no modulation of glutamatergic responses, suggesting that such stimulation may evoke dopamine release from the terminals of nigrostriatal afferents, thereby occluding the effects of exogenously applied agonists 11.
Sources of synaptic Ca influx in striatopallidal MSNs
Our data reveal that, following either single or burst stimulation of an individual synapse, NMDARs contribute the bulk of Ca influx, although both Ca-permeable AMPARs and VGCCs make additional contributions. However, in contrast to hippocampal pyramidal cells 33, we found little contribution of NR2B-containing NMDARs. Similar to hippocampal and cortical pyramidal neurons (reviewed in 38), the major VGCC contributors to synaptic or bAP-evoked spine Ca influx are SNX-482- and mibefradil-sensitive channels. Whereas SNX-482 specifically indicates the presence of R-type (CaV2.3) VGCCs, the non-selective mibefradil suggests contributions from T-type (CaV3) and/or L-type (CaV1.2 and 1.3) channel. Using large voltage steps to directly depolarize the spine, we revealed a nimodipine-sensitive Ca transient, confirming the presence of L-type VGCCs in MSN spines 31. However, these channels either contribute little to synaptic Ca influx or are not effectively blocked by nimodipine during brief depolarizations 30.
An unexpected finding is that blocking either NMDARs or R-type VGCCs increases uEPSP magnitude, a result mimicked by blocking SK-type Ca-activated potassium channels. In the hippocampus and amygdala, Ca influx through these two sources and subsequent opening of SK channels produces local hyperpolarization and inhibits synaptic responses 23,27. Our data suggest that SK channels may play a similar feedback role in MSNs. Surprisingly, quinpirole reduced Ca influx through both NMDARs and R-type VGCCs but did not augment the uEPSP, suggesting that D2Rs may directly regulate SK activation.
Regulation of spine Ca signaling by D2Rs
We found that activation of D2Rs reduces synaptically evoked spine Ca transients mediated by NMDARs. This effect could result from a D2R-mediated reduction in the number of NR2B-containing receptors, which exhibit a higher fractional Ca permeability 33. However, the failure of ifenprodil to alter synaptic Ca transients suggests that these receptors do not contribute substantially under control conditions. Alternatively, D2Rs may regulate NMDAR Ca permeability, consistent with previous studies indicating that fractional permeability for divalent ions can be modified by phosphorylation or structural changes 32,39. Such mechanisms may also be developmentally regulated, as studies in other brain regions indicate that relative NR2B expression levels and PKA-dependent modulation of NMDAR Ca permeability are greater in young animals 32,40. As our experiments were performed in juvenile mice, it will be important to determine whether D2R actions on striatal NMDARs are similarly developmentally regulated.
Modulation of NMDAR Ca transients was mimicked and occluded by pharmacologically inhibiting PKA activity, consistent with the biochemical coupling of D2Rs to Gαi and downstream inhibition of cAMP generation and PKA activity 6. Moreover, blocking the activity of A2ARs, which are positively coupled to cAMP production and PKA activity via Gαs 7, similarly reduced NMDAR Ca influx and occluded the actions of quinpirole. Furthermore, the actions of D2Rs were prevented by co-application of an A2AR agonist. These results suggest that basal A2AR tone facilitates NMDAR-mediated Ca entry, but that D2Rs and A2ARs act competitively to control synaptic Ca influx. Activation of A2ARs also boosted the uEPSC amplitude, possibly reflecting enhancement of current through extrasynaptic receptors. Importantly, although biochemical experiments have demonstrated that PKA may increase phosphorylation of both AMPARs and NMDARs either directly or indirectly via DARPP-32-dependent inhibition of protein phosphatase 1 41,42, our results provide the first description of a functional consequence for D2R- or A2AR-mediated control of PKA on synaptic transmission. D2R signaling via release of Gβγ subunits is known to produce a membrane-delimited PLC- and calcineurin-dependent inhibition of whole-cell Ca currents through VGCCs 12,13. This alternative pathway may underlie the previously reported D2R-mediated reduction in bAP-evoked Ca influx 43 and is consistent with our finding that inhibition of R-type VGCCs is independent of PKA activity. Although reduction in dendritic excitability might also decrease bAP-evoked Ca influx through VGCCs by limiting local depolarization 43, our analysis of relatively proximal spines (<60 μM from the soma) suggests this mechanism is unlikely to explain the present findings. Nevertheless, it is possible that dopaminergic modulation may be different in more distal dendritic regions.
Implications for striatal plasticity
Plasticity of glutamatergic synapses in the striatum is thought to represent a key substrate for both normal and pathological motor learning and is strongly regulated by dopaminergic activity 2,44. In striatopallidal neurons, activation of D2Rs during pairing of pre-and postsynaptic activity is sufficient to convert NMDAR-dependent long-term potentiation (LTP) into long-term depression (LTD), and this switch is prevented by co-activation of A2ARs 19. Our finding that D2R and A2AR activities bidirectionally control NMDAR-mediated Ca influx provides a potential mechanism for these observations. Interestingly, striatal LTD, which is dependent on the activation of postsynaptic metabotropic glutamate receptors, Ca influx through L-type VGCCs, and retrograde endocannabinoid signaling, is disrupted by antagonism of D2Rs 16,20,21. Additionally, both genetic and pharmacological deletion of D2R signaling converts LTD into LTP 16,19. However, the mechanisms underlying D2R control of LTD are unclear. One hypothesis suggests that D2Rs enhance the release of endocannabinoids from spines via a Gβγ-dependent activation of PLC, leading to retrograde inhibition of glutamate release 11,20,45. This possibility is supported by our observation that D2R-medidated inhibition of VGCCs occurs via a PKA-independent pathway. Thus, we propose a model of striatal long-term plasticity where NMDAR-dependent LTP and endocannabinoid-dependent LTD compete to determine net synaptic strength. In this model, D2Rs tip the balance in favor of depression by simultaneously (1) reducing NMDAR-mediated Ca influx via a PKA-dependent process and (2) reducing VGCC-mediated Ca influx and likely enhancing endocannabinoid production via PKA-independent signaling. In summary, our findings highlight the existence of local neuromodulatory actions on synaptic transmission and provide new insight into the role of dopaminergic modulation in the striatum.
Slice preparation and pharmacology
All animal handling was performed in accordance with guidelines approved by the Harvard Institutional Animal Care and use Committee and federal guidelines. Recordings were made from green-fluorescing MSNs in striatal slices taken from male and female postnatal day 15–22 drd2-GFP mice 15,22 or Emx-Cre/drd2-GFP mice (see below) that were euthanized under isoflurane anesthesia. Coronal slices (300 μm thick) were cut in ice-cold external solution containing 110 mM choline, 25 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM KCl, 7 mM MgCl2, 0.5 mM CaCl2, 25 mM glucose, 11.6 mM sodium ascorbate, and 3.1 mM sodium pyruvate, bubbled with 95% O2 and 5% CO2. Slices were then transferred to ACSF containing 127 mM NaCl, 25 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, and 25 mM glucose, bubbled with 95% O2 and 5% CO2. After an incubation period of 30–40 minutes at 34°C, the slices were maintained at 22–25°C until use. All experiments were conducted at 32°C. In all experiments, the ACSF included 50 μM picrotoxin to block GABAA/C receptor-mediated inhibition and 10 μM scopolamine to block confounding actions of muscarinic acetylcholine receptors. For all glutamate uncaging experiments, 10 μM serine was included in the ACSF to reduce NMDAR desensitization. For some experiments (see text), extracellular MgCl2 was reduced to nominally 0 mM. Finally, in some experiments (see text), one or more of the following drugs were added to the ACSF at the following concentrations (in μM): 8 quinpirole, 10 CPP, 10 NBQX, 3 ifenprodil, 1 TTX, 10 mibefradil, 0.1 SNX-482, 0.2 agatoxin IVA, 1 ω-conotoxin GVIA, 3 or 20 nimodipine, 0.1 apamin, 1 PKI(14-22), 10 H89, 0.2 CGS-21680, 0.1 SCH-58261. All chemicals were from Tocris, with the exception of SNX-482, agatoxin IVA and ω-conotoxin GVIA which were from Peptides International, Inc.
Electrophysiology and imaging
Whole-cell recordings were obtained from D2R-expressing MSNs identified with video-IR/DIC and GFP epifluorescence. 2-photon laser scanning microscopy (2PLSM) confirmed the presence of prominent dendritic spines. For current clamp recordings, glass electrodes (2–3.5 MΩ) were filled with internal solution containing (in mM): 135 KMeSO3, 10 HEPES, 4 MgCl2, 4 Na2ATP, 0.4 NaGTP, and 10 Na2CreatinePO4, adjusted to pH 7.3 with KOH. For voltage clamp recordings, cesium was substituted for potassium to improve space clamp. For Ca imaging experiments, either 150 μM (Figs. 5 and and8),8), 600 μM (Fig. 6) or 300 μM (all other experiments) of the Ca sensitive indicator Fluo-5F and 10 μM Alexa Fluor-594 were added. As previous work has shown that membrane potential influences the Ca sources activated during synaptic transmission 28, for current clamp recordings, cells were held near −60mV to approximate the conditions of MSNs in vivo 46. Voltage clamp experiments were performed with a holding potential of −70mV. All recordings were made using a Axopatch 200B amplifier, and data was filtered at 5 kHz and digitized at 10 kHz. For electrical activation of excitatory input fibers, brief (0.2 ms) current injections were applied to a small glass electrode (tip diameter 2 – 4 μm) filled with ACSF and placed at the border between the striatum and the overlying white matter, 100–300 μm from the recorded cell.
Intracellular Ca imaging and glutamate uncaging were accomplished with a custom microscope, as previously described 28. The microscope was assembled using components manufactured by the Harvard Medical School Department of Neurobiology machine shop or Mike’s Machine Company (Attleboro, MA). Neurons were filled via the patch electrode for 10–15 minutes before imaging. Fluo-5F (green) and Alexa Fluor-594 (red) were excited using 840 nm light to monitor Ca signals and spine morphology, respectively. To measure Ca signals, green and red fluorescence were collected during 500 Hz line scans across a spine and a neighboring dendrite. Reference frame scans were taken between each acquisition in order to correct for small spatial drift of the preparation over time. Ca signals were first quantified as increases in green fluorescence from baseline normalized to the average red fluorescence (ΔG/R). The elevated resting green fluorescence due to GFP expression slightly increases shot noise but does not alter the Ca-dependent signal magnitude or the linearity of the response. To allow greater generalization of the data across various microscope configurations, fluorescence changes are expressed as the percentage of the G/R ratio measured in saturating Ca (Gsat/R) in a sealed recording pipette. To calculate Gsat/R, a 1:1 mixture of internal solution and 1 M CaCl2 was imaged in the specimen plane under conditions identical to those used during recordings.
For 2PLU experiments, MNI-glutamate was bath applied at 2.5 mM, and glutamate uncaging was achieved using a 0.5 ms pulse of 725 nm light. In order to achieve standard uncaging power (which translates into a constant amount of glutamate uncaged on each trial), we used photobleaching of Alexa Fluo-594 in the spine of interest as previously described 23. Bleaching is a function of the laser power and provides a readout of power delivery that is independent of spine depth in the slice and electrophysiological responses.
Viral Channelrhodopsin-2 expression and activation
To selectively express a conditional form of the light-activated membrane channel Channelrhodopsin-2 (ChR2) 47 in corticostriatal afferents, we crossed drd2-GFP mice with mice expressing Cre recombinase under control of the Emx1 promoter 48. At postnatal day 12, the F1 offspring of these lines were injected intracranially into somatomotor cortex under isoflurane anesthesia with 1.0 μl of a recombinant adenoassociated virus (serotype 2/8, Harvard Gene Therapy Institute) containing a double-floxed inverted construct coding for the fusion protein Channelrhodopsin2-mCherry under control of the Ef1a promoter 47. After 7–10 days post-injection, mice were euthanized for slice preparation as above and exhibited strong labeling of descending cortical fibers that arborized throughout the dorsal striatum (Fig. 1b). To activate Channelrhodopsin2-positive fibers, light from a 473 nm laser (Optoengine) was focused on to the back aperture of the microscope objective, producing a wide-field exposure around the recorded MSN of 10–20 mW/mm2. Brief (1–2 ms) pulses of light were delivered under control of the acquisition software.
Data acquisition and analysis
Imaging and physiology data were acquired using National Instruments data acquisition boards and custom software written in MATLAB (Mathworks) 49. Off-line analysis was performed using custom routines written in MATLAB and Igor Pro (Wavemetrics). The amplitudes of all EPSPs and non-NMDAR-mediated EPSCs were calculated by averaging over a 3 ms window around the peak, whereas a 10 ms window was used to calculate amplitudes of NMDAR-mediated EPSCs. The amplitudes of triplet burst-evoked uEPSPs were calculated around the peak response following the 3rd stimulus. For imaging experiments, measurements of ΔG/Gsat were calculated by taking the average of the signal over a 150 ms post-stimulus window.
In sections describing optical or uncaging responses measured from individual spines, the stated n indicates the number of spines analyzed. In sections describing electrically-evoked synaptic responses, the stated n indicates the number of cells analyzed. All summary graphs and data are expressed as mean ± SEM and comparisons were made using a two-tailed Student’s t-test unless otherwise stated. Differences were judged statistically significant for p<0.05.
1
Supplemental Figure 1. Activation of D2Rs does not alter electrically-evoked synaptic responses in striatopallidal MSNs.
left, Single EPSPs recorded from a striatopallidal MSN in control conditions (black) and after wash-in of quinpirole (red). middle, Time course of the evoked EPSP amplitude from the experiment shown at the left. Quinpirole was applied during the time indicated by the horizontal bar. right, Peak values for the evoked EPSPs for each recorded cell (n=6, closed circles) in control conditions (black) and after quinpirole wash-in (red). The average population data are also shown (open circles).
Supplemental Figure 2. Temporal summation of uncaging- and bAP-evoked responses. (a) Population data (mean ± SEM) for the peak values of the 3rd uEPSP evoked by a triple uncaging pulse, expressed as a percentage of the 1st uEPSP peak value, for the experimental conditions indicated below: control (Ctl), quinpirole alone (Quin), the NMDAR blockade (CPP), mibefradil (Mib), SNX-482 (SNX), ω-agatoxin IVA (Aga), ω-conotoxin GVIA (GVIA), nimodipine (Nim).
(b) Population data (mean ± SEM) for the ΔCasp evoked by a triple uncaging pulse, expressed as a percentage of the response to a single uncaging pulse, for the conditions indicated below, as in (a).
(c) Population data (mean ± SEM) for the ΔCasp evoked by a triple bAP, expressed as a percentage of the response to a single bAP, for the conditions indicated below, as in (a).
Supplemental Figure 3. Uncaging-evoked EPSPs are enhanced by blocking SK-type Ca-activated potassium channels.
left, Uncaging-evoked uEPSPs (upper traces) and associated ΔCasp (lower traces) recorded in control conditions (black) and in the presence of the SK channel blocker apamin (red). Mean (solid lines) and mean ± SEM (shaded regions) are shown. right, Population data for uEPSP amplitude and ΔCasp expressed as percentage of control values for the data illustrated at the left.
* indicates a significant difference (p<0.05).
Supplemental Figure 4. Uncaging-evoked ΔCa is reduced by a high concentration of nimodipine.
(a) Uncaging-evoked uEPSPs (upper traces) and associated ΔCasp (lower traces) produced by single (left) or triple (right) uncaging pulses are illustrated. Mean (solid colored lines) and mean ± SEM (shaded colored regions) are shown for responses evoked in the presence of 20 μM nimodipine (n=21). Light gray shaded regions indicate the mean ± SEM responses under control conditions, reproduced from Fig. 2.
(b) Population data (mean ± SEM) for peak uEPSP (left) and ΔCasp (right), expressed as a percentage of the control value, for the data illustrated in (a).
* indicates a significant difference (p<0.05).
Acknowledgments
The authors thank members of the Sabatini lab and J.A. Cardin for helpful comments during the preparation of this manuscript. We thank Karl Deisseroth and Viviana Gradinaru for assistance with the ChR2 experiments. The work was funded by grants from the Parkinson’s Disease Foundation (Postdoctoral Fellowship) and NINDS (NS063663) to MJH and grants from NINDS (NS046579) and NARSAD (Independent Investigator Award) to BLS.
1. Graybiel AM. The basal ganglia. Curr Biol. 2000;10:R509–511. [PubMed]
2. Kreitzer AC, Malenka RC. Striatal plasticity and basal ganglia circuit function. Neuron. 2008;60:543–554. [PMC free article] [PubMed]
3. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007;30:228–235. [PubMed]
4. Bonci A, Hopf FW. The dopamine D2 receptor: new surprises from an old friend. Neuron. 2005;47:335–338. [PubMed]
5. Meltzer HY. What’s atypical about atypical antipsychotic drugs? Curr Opin Pharmacol. 2004;4:53–57. [PubMed]
6. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78:189–225. [PubMed]
7. Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferre S. Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol. 2007;83:277–292. [PMC free article] [PubMed]
8. Hersch SM, et al. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci. 1995;15:5222–5237. [PubMed]
9. Cepeda C, Buchwald NA, Levine MS. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci U S A. 1993;90:9576–9580. [PubMed]
10. Bamford NS, et al. Dopamine modulates release from corticostriatal terminals. J Neurosci. 2004;24:9541–9552. [PubMed]
11. Yin HH, Lovinger DM. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci U S A. 2006;103:8251–8256. [PubMed]
12. Hernandez-Lopez S, et al. D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J Neurosci. 2000;20:8987–8995. [PubMed]
13. Olson PA, et al. G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. J Neurosci. 2005;25:1050–1062. [PubMed]
14. Salgado H, et al. A reconfiguration of CaV2 Ca2+ channel current and its dopaminergic D2 modulation in developing neostriatal neurons. J Neurophysiol. 2005;94:3771–3787. [PubMed]
15. Wang Z, et al. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron. 2006;50:443–452. [PubMed]
16. Calabresi P, et al. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J Neurosci. 1997;17:4536–4544. [PubMed]
17. Pawlak V, Kerr JN. Dopamine receptor activation is required for corticostriatal spike-timing-dependent plasticity. J Neurosci. 2008;28:2435–2446. [PubMed]
18. Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson’s disease models. Nature. 2007;445:643–647. [PubMed]
19. Shen W, Flajolet M, Greengard P, Surmeier DJ. Dichotomous dopaminergic control of striatal synaptic plasticity. Science. 2008;321:848–851. [PMC free article] [PubMed]
20. Kreitzer AC, Malenka RC. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci. 2005;25:10537–10545. [PubMed]
21. Ronesi J, Lovinger DM. Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J Physiol. 2005;562:245–256. [PubMed]
22. Heintz N. BAC to the future: the use of bac transgenic mice for neuroscience research. Nat Rev Neurosci. 2001;2:861–870. [PubMed]
23. Bloodgood BL, Sabatini BL. Nonlinear regulation of unitary synaptic signals by CaV(2.3) voltage-sensitive calcium channels located in dendritic spines. Neuron. 2007;53:249–260. [PubMed]
24. Busetto G, Higley MJ, Sabatini BL. Developmental presence and disappearance of postsynaptically silent synapses on dendritic spines of rat layer 2/3 pyramidal neurons. J Physiol. 2008;586:1519–1527. [PubMed]
25. Carter AG, Soler-Llavina GJ, Sabatini BL. Timing and location of synaptic inputs determine modes of subthreshold integration in striatal medium spiny neurons. J Neurosci. 2007;27:8967–8977. [PubMed]
26. Higley MJ, Soler-Llavina GJ, Sabatini BL. Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration. Nat Neurosci. 2009;12:1121–1128. [PMC free article] [PubMed]
27. Faber ES, Delaney AJ, Sah P. SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala. Nat Neurosci. 2005;8:635–641. [PubMed]
28. Carter AG, Sabatini BL. State-dependent calcium signaling in dendritic spines of striatal medium spiny neurons. Neuron. 2004;44:483–493. [PubMed]
29. Furukawa T, et al. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes. Eur J Pharmacol. 2009;613:100–107. [PubMed]
30. Lipscombe D, Helton TD, Xu W. L-type calcium channels: the low down. J Neurophysiol. 2004;92:2633–2641. [PubMed]
31. Day M, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci. 2006;9:251–259. [PubMed]
32. Skeberdis VA, et al. Protein kinase A regulates calcium permeability of NMDA receptors. Nat Neurosci. 2006;9:501–510. [PubMed]
33. Sobczyk A, Scheuss V, Svoboda K. NMDA receptor subunit-dependent [Ca2+] signaling in individual hippocampal dendritic spines. J Neurosci. 2005;25:6037–6046. [PubMed]
34. Wong DF, et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science. 1986;234:1558–1563. [PubMed]
35. Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science. 1975;188:1217–1219. [PubMed]
36. Drew MR, et al. Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci. 2007;27:7731–7739. [PubMed]
37. Wang H, Pickel VM. Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol. 2002;442:392–404. [PubMed]
38. Higley MJ, Sabatini BL. Calcium signaling in dendrites and spines: practical and functional considerations. Neuron. 2008;59:902–913. [PubMed]
39. Burnashev N, et al. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science. 1992;257:1415–1419. [PubMed]
40. Hoffmann H, Gremme T, Hatt H, Gottmann K. Synaptic activity-dependent developmental regulation of NMDA receptor subunit expression in cultured neocortical neurons. J Neurochem. 2000;75:1590–1599. [PubMed]
41. Hakansson K, et al. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J Neurochem. 2006;96:482–488. [PubMed]
42. Westphal RS, et al. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science. 1999;285:93–96. [PubMed]
43. Day M, Wokosin D, Plotkin JL, Tian X, Surmeier DJ. Differential excitability and modulation of striatal medium spiny neuron dendrites. J Neurosci. 2008;28:11603–11614. [PMC free article] [PubMed]
44. Calabresi P, Picconi B, Tozzi A, Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 2007;30:211–219. [PubMed]
45. Giuffrida A, et al. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci. 1999;2:358–363. [PubMed]
46. Mahon S, Deniau JM, Charpier S. Relationship between EEG potentials and intracellular activity of striatal and cortico-striatal neurons: an in vivo study under different anesthetics. Cereb Cortex. 2001;11:360–373. [PubMed]
47. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science. 2009;324:354–359. [PubMed]
48. Gorski JA, et al. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci. 2002;22:6309–6314. [PubMed]
49. Pologruto TA, Sabatini BL, Svoboda K. ScanImage: flexible software for operating laser scanning microscopes. Biomed Eng Online. 2003;2:13. [PMC free article] [PubMed]